GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Nhu Co Ltd (SZSE:002001) » Definitions » EV-to-Revenue

Zhejiang Nhu Co (SZSE:002001) EV-to-Revenue : 4.08 (As of May. 23, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Nhu Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Zhejiang Nhu Co's enterprise value is ¥65,359 Mil. Zhejiang Nhu Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥16,003 Mil. Therefore, Zhejiang Nhu Co's EV-to-Revenue for today is 4.08.

The historical rank and industry rank for Zhejiang Nhu Co's EV-to-Revenue or its related term are showing as below:

SZSE:002001' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.47   Med: 4.56   Max: 9.33
Current: 4.08

During the past 13 years, the highest EV-to-Revenue of Zhejiang Nhu Co was 9.33. The lowest was 2.47. And the median was 4.56.

SZSE:002001's EV-to-Revenue is ranked worse than
70.66% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.325 vs SZSE:002001: 4.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Zhejiang Nhu Co's stock price is ¥19.44. Zhejiang Nhu Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥5.13. Therefore, Zhejiang Nhu Co's PS Ratio for today is 3.79.


Zhejiang Nhu Co EV-to-Revenue Historical Data

The historical data trend for Zhejiang Nhu Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Nhu Co EV-to-Revenue Chart

Zhejiang Nhu Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.92 7.22 5.48 3.87 3.80

Zhejiang Nhu Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.94 3.56 3.72 3.80 3.54

Competitive Comparison of Zhejiang Nhu Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Nhu Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zhejiang Nhu Co's EV-to-Revenue falls into.



Zhejiang Nhu Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Zhejiang Nhu Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=65359.451/16003.074
=4.08

Zhejiang Nhu Co's current Enterprise Value is ¥65,359 Mil.
Zhejiang Nhu Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥16,003 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Nhu Co  (SZSE:002001) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Zhejiang Nhu Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=19.44/5.131
=3.79

Zhejiang Nhu Co's share price for today is ¥19.44.
Zhejiang Nhu Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5.13.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Nhu Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zhejiang Nhu Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Nhu Co (SZSE:002001) Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Jiangbei Road, Yulin Street, Xinchang County, Zhejiang Province, Shaoxing, CHN, 312500
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.

Zhejiang Nhu Co (SZSE:002001) Headlines

No Headlines